Tuesday, June 7, 2022
- 7:00pm-8:00pm
-
Understanding the Impact of Financial Obstacles and Reimbursement for Lost Wages on the Decision-Making Process for Living Organ Donation
Health Equity and Access • Hynes Halls C & D
- 7:00pm-8:00pm
-
Use of Dd-cfdna to Guide Tapering of Immunosuppression Therapy in Kidney Transplant Recipients
Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D
- 7:00pm-8:00pm
-
Use of De Novo mTOR Inhibitors in Highly Sensitized Kidney Transplant Recipients
Kidney Immunosuppression: Novel Regimens and Drug Minimization • Hynes Halls C & D
- 7:00pm-8:00pm
-
Use of Kidneys from Hepatitis C Nat Positive Donors for Uninfected Recipients: Early Results from a Rural Appalachian Kidney Transplant Program
Non-Organ Specific: Viral Hepatitis • Hynes Halls C & D
- 7:00pm-8:00pm
-
Use of Monoclonal Antibody Casirivimab-Imdevimab for Treatment of COVID-19 in Kidney Transplant Recipients
All Infections (Excluding Kidney & Viral Hepatitis) IV • Hynes Halls C & D
- 7:00pm-8:00pm
-
Use of Viral Specific T Cell Therapy in Solid Organ Transplant Recipients – A Single Center Experience
All Infections (Excluding Kidney & Viral Hepatitis) IV • Hynes Halls C & D
- 7:00pm-8:00pm
-
Utility of Donor Derived Cell-Free DNA in Liver Transplantation
Biomarkers: Clinical Outcomes • Hynes Halls C & D
- 7:00pm-8:00pm
-
Utilization of a Pharmacy Technician to Improve Immunization Rates for Pediatric Heart and Kidney Transplant Recipients
Pharmacy II • Hynes Halls C & D
- 7:00pm-8:00pm
-
Utilizing Microporous Annealed Particle (MAP) Gel as an Immunomodulatory Carrier for Islet Delivery
Translational Cellular Therapies: Islet and Stem Cell Transplantation • Hynes Halls C & D
- 7:00pm-8:00pm
-
Validation of Trugraf Gene Expression Profile in a Multicenter Cohort (TOGETHER Study)
Biomarkers: Clinical Outcomes • Hynes Halls C & D